Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02522884 · ClinicalTrials.gov registry record · NA
Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries
A NA study, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- NA
- Development phase
- 213
- Enrollment target
NCT02522884 is a NA study that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 213 participants.
The verdict
NCT02522884, a NA study, has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- NA
- Development phase
- 213 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, single-arm, non-blinded study designed to investigate the safety and efficacy of the Tack Endovascular System in subjects with post-balloon angioplasty (post-PTA) dissection(s) type(s) A through F in the superficial femoral and proximal popliteal arteries ranging in diameter from 2.5mm to 6.0mm.
Interventions
- DEVICE Tack Endovascular System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2015-09 |
| Est. Completion | 2020-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02522884
The ClinicalTrials.gov registry entry for NCT02522884 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tack Endovascular System is the first listed.
NCT02522884 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02522884 about?
NCT02522884 is a clinical study titled "Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries". This is a prospective, multi-center, single-arm, non-blinded study designed to investigate the safety and efficacy of the Tack Endovascular System in subjects with post-balloon angioplasty (post-PTA) dissection(s) type(s) A through F in the superficial femoral and proximal popliteal arteries ranging...
What is the current status of trial NCT02522884?
This trial is currently completed. It is a NA study. The enrollment target is 213 participants. The study started on 2015-09. Estimated completion is 2020-03.
What interventions are being tested in trial NCT02522884?
The interventions under investigation include: Tack Endovascular System (DEVICE).
Who is sponsoring clinical trial NCT02522884?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.